Funder
Research and Technology Innovation Fund
Breast Cancer Research Foundation
Novo Nordisk Foundation Interdisciplinary Synergy Programme
New National Excellence Program of the Ministry of Human Capacities
Tesaro Inc.
Danish Cancer Society
Reference21 articles.
1. CNS metastases in breast cancer;Lin;J Clin Oncol,2004
2. The shifting landscape of metastatic breast cancer to the CNS;Quigley;Neurosurg Rev,2013
3. Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer;Mirza;N Engl J Med,2016
4. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation;Robson;N Engl J Med,2017
5. Abstract B168: the PARP inhibitor, niraparib, crosses the blood brain barrier in rodents and is efficacious in a BRCA2-mutant intracranial tumor model;Mikule;Mol Cancer Ther,2015
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献